Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/ID/Boise
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Boise, ID

Studies commonly pay $75 to $4,500 per completed study

252 clinical trials are currently recruiting participants within 30 miles of Boise. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

252studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Boise right now

Top 25 of 252 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (1.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
St. Luke's Cancer Institute: Boise — Boise, Idaho (1.6 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (1.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05561387)

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought
Saint Alphonsus Regional Medical Center ( Site 0067) — Boise, Idaho (1.6 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06136559)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (1.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05675410)

The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry

Cesarean Delivery, General Anesthesia N/A Observational 5,000 participants sought
St Lukes Anesthesia Associates of Boise — Boise, Idaho (1.6 mi) · Sponsor: Yale University
See eligibility & contact on ClinicalTrials.gov (NCT06030063)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Malignant Glioma Phase 1, Phase 2 Interventional 132 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (1.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05099003)

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Asthma Phase 3 Interventional 440 participants sought
Research Site — Meridian, Idaho (8.1 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06307665)

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis Phase 3 Interventional 675 participants sought
Treasure Valley Medical Research /ID# 266838 — Boise, Idaho (1.6 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06461897)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 189 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT02734537)

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Menstrual Migraine Phase 3 Interventional 723 participants sought
St Luke's Clinic - Neurology — Meridian, Idaho (8.1 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06641466)

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 93 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (1.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06672146)

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

Acute Respiratory Distress Syndrome (ARDS), ARDS Phase 2 Interventional 200 participants sought
St. Luke's Boise Medical Center — Boise, Idaho (1.6 mi) · Sponsor: PPD Development, LP
See eligibility & contact on ClinicalTrials.gov (NCT06701656)

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer Phase 3 Interventional 600 participants sought
St. Luke's Cancer Institute — Boise, Idaho (1.6 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06793215)

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction Phase 3 Interventional 5,056 participants sought
High Desert Heart and Vascular — Meridian, Idaho (8.1 mi) · Sponsor: Amgen
See eligibility & contact on ClinicalTrials.gov (NCT07037459)

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Type 2 Diabetes Phase 3 Interventional 55 participants sought
St. Luke's Children's Endocrinology and Diabetes — Boise, Idaho (1.6 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06739122)

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Phase 3 Interventional 466 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07321652)

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought
St. Luke's Idaho Cardiology Associates — Meridian, Idaho (8.1 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT06118281)

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

Basal Ganglia Germinoma, Diabetes Insipidus Phase 2 Interventional 240 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (1.6 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT06368817)
Actively enrolling

Studies you may be able to join near Boise

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Boise

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

NORTHWEST CLINICAL TRIALS

★ 4.6
888 N Cole Rd, Boise, ID 83704
(208) 685-0600
"Staff is extremely knowledgeable. I always felt welcomed each visit I had with them. Terry is down to earth and Dr. Brock is very easy to talk to. Hi…"
— Alex Shriver, 5★

Treasure Valley Medical Research

★ 4.9
1000 N Curtis Rd Ste 102, Boise, ID 83706
(208) 813-6505
"Great people<br>My asthma care has never been treated so well<br>Being on one of there studies has made my asthma problems have been in check. I have…"
— John Nye, 5★

Advanced Specialty Research ASR

★ 4.9
200 N 3rd St Apt 110, Boise, ID 83702
(208) 906-1600
"I've had an amazing experience with ASR!! Their staff has been amazing and Tati provides the best customer service experience everytime! She is pro…"
— Robert Kern, 5★

Paradigm Clinical Research

959 S Allante Pl, Boise, ID 83709
(208) 801-7440

Solaris Clinical Research

★ 4.5
1525 E Leigh Fld Dr #100, Meridian, ID 83646
(208) 288-0123
"I was in the area checking out a different business and checked this one out. They are repainting and giving a fresh new cost of paint and this place…"
— Timothy Bird, 4★

Velocity Clinical Research

★ 4.7
2950 E Magic View Dr #100, Meridian, ID 83642
(208) 377-8653
"I've participated in multiple clinical trials through Velocity Clinical Research and each time my experience has been great. The staff has been very…"
— Kevin Riley, 5★

Injury Care Research

★ 4.7
4850 N Rosepoint Way Ste 105, Boise, ID 83713
(208) 621-2503
"Had a very positive experience at this office. Everyone at this office, including Aiden, and Victor were absolutely top notch professionals. All appo…"
— Rick RM Harvey, 5★

Family Care Research

4850 N Rosepoint Way Ste 105, Boise, ID 83713
(208) 621-2503

Idaho Veterans Research and Education Foundation

500 W Fort St, Boise, ID 83724
(208) 422-1000 ext. 4019

Clinical trials in Boise: what's recruiting

The Boise area currently has 252 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Boise, the most active research areas are:

  • Cancer & Oncology14 studies
  • Diabetes & Metabolism4 studies
  • Liver & Kidney2 studies
  • Lungs & Breathing2 studies
  • Heart & Vascular2 studies

Every listing shows the study phase, the recruiting site and its distance from Boise, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Boise

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Boise participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Boise pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Boise?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Boise safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Boise?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Boise.

Paid clinical trials near Boise

Other metros within reach

Nampa, ID252 Kennewick, WA55 Spokane, WA291 Ogden, UT115 Salt Lake City, UT1,145 Reno, NV191 Provo, UT120 Vancouver, WA1,021

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Boise Bladder Issues Due To Spinal Cord Injury in Boise All conditions

More of ID

Nampa252

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts